These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 28881358)

  • 1. Ligand-dependent Hedgehog pathway activation in Rhabdomyosarcoma: the oncogenic role of the ligands.
    Almazán-Moga A; Zarzosa P; Molist C; Velasco P; Pyczek J; Simon-Keller K; Giralt I; Vidal I; Navarro N; Segura MF; Soriano A; Navarro S; Tirado OM; Ferreres JC; Santamaria A; Rota R; Hahn H; Sánchez de Toledo J; Roma J; Gallego S
    Br J Cancer; 2017 Oct; 117(9):1314-1325. PubMed ID: 28881358
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetic-pharmacodynamic analysis of vismodegib in preclinical models of mutational and ligand-dependent Hedgehog pathway activation.
    Wong H; Alicke B; West KA; Pacheco P; La H; Januario T; Yauch RL; de Sauvage FJ; Gould SE
    Clin Cancer Res; 2011 Jul; 17(14):4682-92. PubMed ID: 21610148
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hedgehog signal inhibitor forskolin suppresses cell proliferation and tumor growth of human rhabdomyosarcoma xenograft.
    Yamanaka H; Oue T; Uehara S; Fukuzawa M
    J Pediatr Surg; 2011 Feb; 46(2):320-5. PubMed ID: 21292081
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hedgehog signal inhibitors suppress the invasion of human rhabdomyosarcoma cells.
    Oue T; Uehara S; Yamanaka H; Nomura M; Usui N
    Pediatr Surg Int; 2013 Nov; 29(11):1153-8. PubMed ID: 23989521
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hedgehog/Patched-associated rhabdomyosarcoma formation from delta1-expressing mesodermal cells.
    Nitzki F; Cuvelier N; Dräger J; Schneider A; Braun T; Hahn H
    Oncogene; 2016 Jun; 35(22):2923-31. PubMed ID: 26387541
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Crosstalk between hedgehog and other signaling pathways as a basis for combination therapies in cancer.
    Brechbiel J; Miller-Moslin K; Adjei AA
    Cancer Treat Rev; 2014 Jul; 40(6):750-9. PubMed ID: 24613036
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting PAK4 Inhibits Ras-Mediated Signaling and Multiple Oncogenic Pathways in High-Risk Rhabdomyosarcoma.
    Dasgupta A; Sierra L; Tsang SV; Kurenbekova L; Patel T; Rajapakse K; Shuck RL; Rainusso N; Landesman Y; Unger T; Coarfa C; Yustein JT
    Cancer Res; 2021 Jan; 81(1):199-212. PubMed ID: 33168646
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of the Hedgehog signaling pathway in cancer: A comprehensive review.
    Skoda AM; Simovic D; Karin V; Kardum V; Vranic S; Serman L
    Bosn J Basic Med Sci; 2018 Feb; 18(1):8-20. PubMed ID: 29274272
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hedgehog signaling pathway as a therapeutic target in various types of cancer.
    Onishi H; Katano M
    Cancer Sci; 2011 Oct; 102(10):1756-60. PubMed ID: 21679342
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Primary cilia control hedgehog signaling during muscle differentiation and are deregulated in rhabdomyosarcoma.
    Fu W; Asp P; Canter B; Dynlacht BD
    Proc Natl Acad Sci U S A; 2014 Jun; 111(25):9151-6. PubMed ID: 24927541
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of a novel synthetic lethality of combined inhibition of hedgehog and PI3K signaling in rhabdomyosarcoma.
    Graab U; Hahn H; Fulda S
    Oncotarget; 2015 Apr; 6(11):8722-35. PubMed ID: 25749378
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Constitutive activation of MET signaling impairs myogenic differentiation of rhabdomyosarcoma and promotes its development and progression.
    Skrzypek K; Kusienicka A; Szewczyk B; Adamus T; Lukasiewicz E; Miekus K; Majka M
    Oncotarget; 2015 Oct; 6(31):31378-98. PubMed ID: 26384300
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interfering with Hedgehog Pathway: New Avenues for Targeted Therapy in Rhabdomyosarcoma.
    Manzella G; Schäfer BW
    Curr Drug Targets; 2016; 17(11):1228-34. PubMed ID: 25944015
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hedgehog Pathway Drives Fusion-Negative Rhabdomyosarcoma Initiated From Non-myogenic Endothelial Progenitors.
    Drummond CJ; Hanna JA; Garcia MR; Devine DJ; Heyrana AJ; Finkelstein D; Rehg JE; Hatley ME
    Cancer Cell; 2018 Jan; 33(1):108-124.e5. PubMed ID: 29316425
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hedgehog signaling pathway is activated in diffuse large B-cell lymphoma and contributes to tumor cell survival and proliferation.
    Singh RR; Kim JE; Davuluri Y; Drakos E; Cho-Vega JH; Amin HM; Vega F
    Leukemia; 2010 May; 24(5):1025-36. PubMed ID: 20200556
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discovery of a potent hedgehog pathway inhibitor capable of activating caspase8-dependent apoptosis.
    Chen Q; Zhang H; Wu M; Wang Q; Luo L; Ma H; Zhang X; He S
    J Pharmacol Sci; 2018 Jul; 137(3):256-264. PubMed ID: 30064819
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The intrahepatic signalling niche of hedgehog is defined by primary cilia positive cells during chronic liver injury.
    Grzelak CA; Martelotto LG; Sigglekow ND; Patkunanathan B; Ajami K; Calabro SR; Dwyer BJ; Tirnitz-Parker JE; Watkins DN; Warner FJ; Shackel NA; McCaughan GW
    J Hepatol; 2014 Jan; 60(1):143-51. PubMed ID: 23978713
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacological inhibition of the Hedgehog pathway prevents human rhabdomyosarcoma cell growth.
    Kawabata N; Ijiri K; Ishidou Y; Yamamoto T; Nagao H; Nagano S; Maeda S; Komiya S; Setoguchi T
    Int J Oncol; 2011 Oct; 39(4):899-906. PubMed ID: 21674124
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nonclassical hedgehog-GLI signaling and its clinical implications.
    Shevde LA; Samant RS
    Int J Cancer; 2014 Jul; 135(1):1-6. PubMed ID: 23929208
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Involvement and targeted intervention of dysregulated Hedgehog signaling in osteosarcoma.
    Lo WW; Wunder JS; Dickson BC; Campbell V; McGovern K; Alman BA; Andrulis IL
    Cancer; 2014 Feb; 120(4):537-47. PubMed ID: 24151134
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.